Open‐label, single‐arm, single‐center clinical study on the effectiveness and safety of a moisturizer containing tocotrienol‐rich composition in children with mild to moderate atopic dermatitis
Authors:
Open Access
- 4 May 2023
- journal article
- research article
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (10) , 2746-2754
Abstract
BackgroundLittle is known about antioxidant efficacy of topical vitamin E on atopic dermatitis (AD) due to lack of controlled clinical studies. AimThe study evaluates the effectiveness and safety of a topical moisturizer containing tocotrienol-rich composition over 12 weeks on patients aged between 1 month and 12 years with mild to moderate AD. MethodsWe conducted a 12 weeks, prospective, open-label clinical study on the effect of tocotrienol as an adjunct to conventional treatment. This study was approved by the Ethics Committee for Research Involving Human Subject. JKEUPM-2019-274 (NMMR-19-1588-49234). ResultsThirty AD patients with a mean age of 2.77 +/- 3.05 were enrolled in the study. At week-12, significant reduction of investigator global assessment (63.4%), Patient-Oriented Scoring Atopic Dermatitis Index (PO-SCORAD) (65%), and SCORAD (52.3%) was noted (p < 0.05). There was also a significant decreased in pruritus intensity (46%, p < 0.05). Similarly at week-12, Infant's Dermatitis Quality of Life Index and Children's Dermatology Life Quality Index were found to improve significantly compared to baseline (p < 0.05). Instrumental assessment revealed improvement in TEWL and erythema index, 49.7% and 17.4%, respectively. No adverse reaction was observed. 95% of patients were satisfied with the moisturizer and 90% perceived it to be better than the one in the market. There was a 55.07% reduction in the use of hydrocortisone 1% cream toward the end of the study (p < 0.05). ConclusionsThe results suggested that tocotrienol-rich moisturizer is safe and effective in the management of AD in young children.Keywords
This publication has 23 references indexed in Scilit:
- KM110329 in adult patients with atopic dermatitis: a randomised, double-blind, placebo-controlled, multicentre trial – study protocolBMC Complementary and Alternative Medicine, 2013
- Improvement by sodium dl-α-tocopheryl-6-O-phosphate treatment of moisture-retaining ability in stratum corneum through increased ceramide levelsBioorganic & Medicinal Chemistry, 2012
- Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in EuropeAllergy, 2011
- NF-κB in the regulation of epithelial homeostasis and inflammationCell Research, 2010
- Skin pretreatment with lasers promotes the transdermal delivery of vitamin C derivativesLasers in Medical Science, 2010
- Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trialsBritish Journal of Dermatology, 2010
- Changes in basal cell mitosis and transepidermal water loss in skin cultures treated with vitamins C and EExperimental Dermatology, 2005
- Oxidative Targets in the Stratum corneumSkin Pharmacology and Physiology, 2001
- Efficacy of Topically Applied Tocopherols and Tocotrienols in Protection of Murine Skin From Oxidative Damage Induced by UV-IrradiationFree Radical Biology and Medicine, 1997
- Allergic contact dermatitis from tocopheryl acetate in cosmetic creamsContact Dermatitis, 1991